August 21, 2023, Intelligence: Late-Breaking Lab News

By Scott Wallask | From the Volume XXX, No. 12 – August 21, 2023 Issue

New research about ownership of physician practices will be of interest to anatomic pathologists who operate their own businesses. According to an analysis by the American Medical Association (AMA),…

Read More

---

July 31, 2023, Intelligence: Late-Breaking Lab News

By Scott Wallask | From the Volume XXX, No. 11 – July 31, 2023 Issue

Regulatory relief is on the way for clinical laboratories accredited by The Joint Commission. An overhaul of the Laboratory Accreditation Program’s standards, which goes into effect Aug. 27, will …

Read More

---

QuidelOrtho Earns $3.3 Billion in First Year as Combined Firm

By Robert Michel | From the Volume XXX No. 4 – March 6, 2023 Issue

IN OUR FEBRUARY 13, 2023, ISSUE OF THE DARK REPORT, we analyzed the 2022 full-year and Q4 earnings of major IVD companies. At the time our prior issue went to press, QuidelOrtho had not yet reported its year-end results.  …

Read More

---

2022’s Top 10 Lab Stories Confirm Challenging Times

By Scott Wallask | From the Volume XXIX, No. 17 – December 12, 2022 Issue

CEO SUMMARY: There are valuable insights to be gleaned from The Dark Report’s “Top 10 Lab Industry Stories for 2022.” Several of this year’s story picks involve external forces reshaping healthcare in the United States in profound ways. Other story picks for 2022 illustrate …

Read More

---

Reports Say Qiagen and Bio-Rad Discussing Potential IVD Merger

By Scott Wallask | From the Volume XXIX, No. 15 – October 31, 2022 Issue

More consolidation in the in vitro diagnostics (IVD) mar­ket may soon happen. Bio-Rad Laboratories and Qiagen are reportedly in merger discussions. The Wall Street Journal, which broke the story on Oct. 10, tabbed the potential deal as being worth …

Read More

---

October 10, 2022 Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXIX, No. 14 – October 10, 2022 Issue

Future regulation of laboratory-developed tests (LDTs) may not be as clear as it once appeared. On Sept. 30, Congress passed a short-term resolution to keep the federal government funded. As part of the move, a proposed bill to increase oversight of LDTs has been sidelined, at least for now, accordin…

Read More

---

Lean Is Smart Approach to Major Lab Cost Savings

By Robert Michel | From the Volume XXIX, No. 13 – September 19, 2022 Issue

CEO SUMMARY: It’s a time when clinical labs are under extreme pressure to cut costs, even as they deal with understaffing. One proven approach to reducing expenses while preserving quality is to apply Lean methods in conjunction with Six Sigma tools. It is often true that successf…

Read More

---

2021 Rankings of the World’s Top 12 IVD Companies

By Robert Michel | From the Volume XXIX, No. 12 – August 29, 2022 Issue

WHILE THERE WAS SOME JOCKEYING FOR NEW positions, in vitro diagnostics (IVD) manufacturers remain entrenched in their market based on The Dark Report’s 2021 ranking of the Top 12 IVD Companies.  COVID-1…

Read More

---

In Post-COVID-19 Market, IVD Manufacturers Face Supply, Staff Challenges

By Robert Michel | From the Volume XXIX, No. 10 – July 18, 2022 Issue

CEO SUMMARY: After making billions during the COVID-19 pandemic, in vitro diagnostics (IVD) manufacturers must now adjust their strategies and relationships with clinical laboratory customers. Because many contracts for automated instruments are coming due, some IVD companies have t…

Read More

---

June 6, 2022 Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXIX, No. 8 – June 6, 2022 Issue

Monkeypox is the latest disease showing up in the United States. That means hospital laboratories will want to be ready to diagnose monkeypox cases that show up in their emergency departments. An official from the Centers for Disease Control and Prevention (CDC) says it is exploring the possib…

Read More

---